Janssen Korea, Samjin attack cold medicine market with new packages

Published: 2006-11-28 06:57:00

Updated: 2006-11-28 06:57:00

As the safety containers for children should be equipped with the new pediatric drugs containing acetaminophen or ibuprofen, the domestic market for cold medicines will be contested by two markers Janssen Korea and Samjin Pharm, according to pharmaceutical business sources.

Janssen Korea seems to be busier this season with the release of a new-package Tylenol on November 22.

Samjin is re...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.